EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Antihypertensive Efficacy and Tolerability of Telmisartan over Losartan on Mild to Moderate Hypertension in a Tertiary Care Hospital

Abul Hossain, Suma Rani Pal Pal, Mahadi Masud, Mohammad Farid Uddin Ahmed, Shirin Aktar, Nargis Akter, Shahina Akter, Rozina Afroz, Md Moklesur Rahman, Nuzhat Andalib, Kazi Azajul Ferdoush

Faridpur Medical College Journal · 28.06.2026 · 21 (2) · 13-19

DOI: 10.3329/fmcj.v21i2.90749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Faridpur Medical College Journal, online erschienen am 28.06.2026. Verfasst von Abul Hossain und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Angiotensin II Receptor Blockers (ARBs) are one of the first line drugs for the treatment of hypertension. The objective of the study was to evaluate and compare the efficacy and tolerability between Telmisartan and Losartan in mild to moderate hypertension. Materials & Methods: This prospective analytical study was performed in the Medicine Outpatient Department including Hypertension Clinic of DMCH from January 2022 to December 2022. Total 160 patients with mild to moderate hypertension were divided into two groups; patients in Group A were administered Tab. Telmisartan once daily and patients in group B were administered Tab. Losartan once daily.

Results

At baseline and after 6 weeks, there were no significant differences in mean systolic blood pressure (SBP) and mean diastolic blood pressure (DBP) between the two groups. However, at 12 weeks, both mean SBP and mean DBP were significantly lower in Telmisartan group compared to the Losartan group. Serum sodium, serum potassium and serum creatinine levels showed no significant differences throughout the study period. Adverse effects such as dizziness and vomiting were more frequent in Losartan group.

Conclusion

Telmisartan demonstrated superior efficacy and better tolerability, making it a preferable option for managing mild-to-moderate hypertension. Faridpur Med. Coll. J. 2026;21(2):13-19

Zitieren

APA

Hossain, A., Pal, S. R. P., Masud, M., Ahmed, M. F. U., Aktar, S., Akter, N., Akter, S., Afroz, R., Rahman, M. M., Andalib, N., & Ferdoush, K. A. (2026). Evaluation of Antihypertensive Efficacy and Tolerability of Telmisartan over Losartan on Mild to Moderate Hypertension in a Tertiary Care Hospital. Faridpur Medical College Journal, 21(2), 13-19. https://doi.org/10.3329/fmcj.v21i2.90749

Vancouver

Hossain A, Pal SRP, Masud M, Ahmed MFU, Aktar S, Akter N, et al. Evaluation of Antihypertensive Efficacy and Tolerability of Telmisartan over Losartan on Mild to Moderate Hypertension in a Tertiary Care Hospital. Faridpur Medical College Journal. 2026;21(2):13-19. doi:10.3329/fmcj.v21i2.90749

BibTeX
@article{Hossain2026,
  author = {Hossain, Abul and Pal, Suma Rani Pal and Masud, Mahadi and Ahmed, Mohammad Farid Uddin and Aktar, Shirin and Akter, Nargis and Akter, Shahina and Afroz, Rozina and Rahman, Md Moklesur and Andalib, Nuzhat and Ferdoush, Kazi Azajul},
  title = {Evaluation of Antihypertensive Efficacy and Tolerability of Telmisartan over Losartan on Mild to Moderate Hypertension in a Tertiary Care Hospital},
  journal = {Faridpur Medical College Journal},
  year = {2026},
  volume = {21},
  number = {2},
  pages = {13--19},
  doi = {10.3329/fmcj.v21i2.90749}
}
Kostenlos starten →